|
July. 26, 2019 |
|
|
July. 02, 2025 |
|
|
jRCTs021190007 |
Approach to elucidate the effect of ketamine on treatment resistant depression (AKD) |
|
AKD (AKD) |
Kudo Takashi |
||
Hirosaki University Hospital |
||
53 Honcho Hirosaki Aomori , Japan |
||
+81-172335111 |
||
takf5@hirosaki-u.ac.jp |
||
Kudo Takashi |
||
Hirosaki University Hospital |
||
53 Honcho Hirosaki Aomori , Japan |
||
+81-172-33-5111 |
||
takf5@hirosaki-u.ac.jp |
Recruiting |
Aug. 01, 2019 |
||
| Nov. 10, 2019 | ||
| 30 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
active control |
||
single assignment |
||
treatment purpose |
||
patients with refractory depression diagnosed by psychiatrists |
||
1. patients who has allergy to ketamine |
||
| 20age 0month 0week old over | ||
| 65age 0month 0week old under | ||
Both |
||
refractory depression |
||
1.iv both ketamine 0.5 mg/kg and midazolam 0.04 mg/kg for 40 min |
||
depression |
||
effect of ketamine on refractory depression |
||
assessment of biomarkers after intravenous injection of ketamine |
||
| Hirosaki University General Certified Review Board | |
| 1 Bunkyocho, Hirosaki , Aomori | |
+81-172-39-5362 |
|
| crb-hirosaki@hirosaki-u.ac.jp | |
| Approval | |
July. 01, 2019 |
No |
none |